# A Study to Access the Safety and Efficacy of CT0590 in Patients With Relapsed and/or Refractory Multiple Myeloma

> **NCT05066022** · NA · UNKNOWN · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 24 (estimated)

## Conditions studied

- Relapsed and/or Refractory Multiple Myeloma

## Interventions

- **BIOLOGICAL:** CT0590 CAR T Cells

## Key facts

- **NCT ID:** NCT05066022
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-28
- **Primary completion:** 2022-08-30
- **Final completion:** 2024-07-29
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2021-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05066022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05066022, "A Study to Access the Safety and Efficacy of CT0590 in Patients With Relapsed and/or Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05066022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*